Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: A phase I study

Additional Metadata
Persistent URL	doi.org/10.1016/S0140-6736(01)06535-7, hdl.handle.net/1765/57450
Journal	The Lancet
Organisation	Department of Medical Oncology
Citation APA APA Style APA-ALL Style AAA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	van Oosterom, A., Judson, I., Verweij, J., Stroobants, S., Donato Di Paola, E., Dimitrijevic, S., Martens, M., Webb, A., Sciot, R., van Glabbeke, M., Silberman, S.& Nielsen, O. (2001). Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: A phase I study. The Lancet, 358(9291), 1421–1423.https://doi.org/10.1016/S0140-6736(01)06535-7

Publication